Gender, female, n (%)
|
27 (79.4 %)
|
31 (75.6 %)
|
0.695a
|
20 (80 %)
|
20 (80 %)
|
1.00a
|
7 (77.8 %)
|
11 (68.8 %)
|
0.629a
|
Age, baseline, years, mean (SD)
|
59.3 (12.3)
|
53.3 (10.3)
|
0.023b
|
61.2 (12.2)
|
54.86 (11.4)
|
0.065b
|
54.3 (11.7)
|
50.7 (8.2)
|
0.258b
|
Concurrent DMARDs, n (%)
|
28 (82.4 %)
|
36 (90 %)
|
0.338a
|
22 (88 %)
|
21 (84 %)
|
0.684a
|
6 (66.7 %)
|
15 (100 %)
|
0.017a
|
Baseline DAS28, median (IQR)
|
6.2 (5.4–6.6)
|
5.8 (5.5–6.3)
|
0.131c
|
6.2 (5.8–6.6)
|
5.9 (5.5–6.2)
|
0.156c
|
6.6 (5.6–7.03)
|
5.6 (5.3–6)
|
0.101c
|
3 month DAS28, median (IQR)
|
5.65 (5.4–6.2)
|
2.15 (1.6–2.5)
|
<0.001c
|
5.6 (5.3–5.9)
|
2.3 (1.9–3)
|
<0.001c
|
6.6 (5.3–6.8)
|
1.95 (1.6–2.2)
|
<0.001c
|
Baseline TJC, median (IQR)
|
16 (10–19)
|
13 (10–16)
|
0.205c
|
14 (10–18)
|
13 (10–15)
|
0.515c
|
18 (16–24)
|
13 (10–19)
|
0.157c
|
Baseline SJC, median (IQR)
|
8.5 (4–13)
|
9 (6–13)
|
0.701c
|
7 (4–11)
|
9 (6–13)
|
0.268c
|
11 (9–15)
|
8.5 (6–13)
|
0.211c
|
Baseline ESR, median (IQR), n
|
33 (14–44), 26
|
18 (14–33), 35
|
0.11c
|
32 (23–41), 21
|
18 (10–34), 23
|
0.158c
|
34 (10–60), 5
|
20.5 (14–31), 12
|
0.712c
|
Baseline HAQ, median (IQR), n
|
2.06 (1.38–2.3), 22
|
1.5 (1.13–2), 32
|
0.026c
|
2.1 (1.9–2.3), 17
|
1.4 (1.1–1.6), 19
|
0.006c
|
1.9 (1.3–2.1), 5
|
1.8 (1.1–2.4), 13
|
0.96c
|
Tempus™ Blood Tube, n (%)
|
21 (61.8 %)
|
22 (53.4 %)
|
0.48a
|
15 (60 %)
|
14 (56 %)
|
0.774a
|
6 (66.67 %)
|
8 (50 %)
|
0.420a
|